The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,003.02 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, with a period of performance through December 27, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.
Generated 3/6/25, 9:42 AM